,
your personalized virtual assistant to find clinical trials. Go head, 
Sandeep Soni, MD
Nationwide Children's HospitalColumbus, Ohio - 43205-2696 (614-722-3552) |
- CLINICAL TRIALS 4
- CONDITIONS10
- INTERVENTIONS27
- SINCE2008
Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.
February 2010 - January 2014
Fludarabine Busulfan and Antithymocyte Globulin Followed By Donor Stem Cell Transplant in Treating Young Patients With High-Risk Neuroblastoma That Has Relapsed or Not Responded to Treatment
September 2008 - June 2011
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
August 2010 - December 2013
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
August 2010 - August 2013
Leukemia
Leukemia, Lymphoid
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Acute Disease
Neuroblastoma
Neoplasm, Residual
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Stem Cell Infusion
Laboratory Biomarker Analysis
Busulfan
Immunoenzyme Technique
Gene Expression Analysis
Prednisone
Anti-Thymocyte Globulin
Cyclosporine
Methotrexate
Tacrolimus
Allogeneic Bone Marrow Transplantation
Fludarabine Phosphate
Mycophenolate Mofetil
Allogeneic Hematopoietic Stem Cell Transplantation
Cytarabine
Pegaspargase
Polymerase Chain Reaction
Flow Cytometry
Peripheral Blood Stem Cell Transplantation
Graft-Versus-Tumor Induction Therapy
Clofarabine
Total Body Irradiation
Cyclosporins
Doxorubicin
Vincristine
Enzyme-Linked Immunosorbent Assay
Ezn-3042
